Tindamax Related Published Studies
Well-designed clinical trials related to Tindamax (Tinidazole)
Tinidazole vs metronidazole for the treatment of bacterial vaginosis. [2011.03]
Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. [2009.02]
Effectiveness of Two Tinidazole Regimens in Treatment of Bacterial Vaginosis: A Randomized Controlled Trial. [2007.08]
A randomized, controlled, open-label trial of a single day of mebendazole versus a single dose of tinidazole in the treatment of giardiasis in children. [2006.11]
One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection. [2005.09]
Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. [2003.12]
Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial. [2003.07.01]
Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis. [2003.06]
Efficacy and tolerability of a combination of ofloxacin and tinidazole in the management of infectious diabetic foot ulcer. [2003.05]
Omeprazole plus azithromycin and either amoxicillin or tinidazole for eradication of Helicobacter pylori infection. [2003.04]
Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication. [2002.01]
Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection. [2001.08]
Pantoprazole, azithromycin and tinidazole: short duration triple therapy for eradication of Helicobacter pylori infection. [2000.12]
The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group. [2000.06]
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection. [2000.01]
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection. [1999.12]
Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study. [1999.03]
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. [1998.06]
Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study. [1997.11]
[The effect of tinidazole in the treatment of adult periodontitis] [1996.09]
Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. [1996.06]
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients. [1996.03]
Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study. [1995.09]
A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. [1993.10]
Tinidazole prophylaxis in elective abdominal hysterectomy. [1993.08]
Split-dose metronidazole or single-dose tinidazole for the treatment of vaginal trichomoniasis. [1992.09]
[Treatment of bacterial vaginitis. Multicenter, randomized, open study with tinidazole in comparison with metronidazole] [1991.02.20]
Seven day metronidazole versus single dose tinidazole as therapy for nonspecific vaginitis. [1990.05]
Treatment of asymptomatic amebiasis in homosexual men. Clinical trials with metronidazole, tinidazole, and diloxanide furoate. [1990.04]
Prophylactic use of phenoxymethylpenicillin and tinidazole in mandibular third molar surgery, a comparative placebo controlled clinical trial. [1990.02]
Antibiotic prophylaxis in colorectal surgery. Combined doxycycline-tinidazole vs. doxycycline alone. [1989.02]
Anaerobic vaginosis: treatment with tinidazole vaginal tablets. [1989]
Comparison of tinidazole given as a single dose and on 2 consecutive days for the treatment of nonspecific bacterial vaginosis. [1988]
Well-designed clinical trials possibly related to Tindamax (Tinidazole)
Development of a novel LC-MS/MS method for the determination of letosteine in human plasma and its application on pharmacokinetic studies. [2011.09.01]
Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial. [2011.07]
Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. [2011.01.15]
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. [2010.11]
Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability. [2010.04]
Standard triple, bismuth pectin quadruple and sequential therapies for
Helicobacter pylori eradication. [2010]
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. [2009.12]
Pharmacokinetics, safety and tolerance of single- and multiple-dose of a novel compound tramadol hydrochloride injection (35 mg tramadol hydrochloride, 45 mgl promethazine hydrochloride) in Chinese healthy subjects. [2009.07]
Antiamoebic drugs for treating amoebic colitis. [2009.04.15]
The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. [2009.04]
[Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis] [2008.08.12]
A comparative study of injection placentrex and conventional therapy in treatment of pelvic inflammatory disease. [2008.07]
Smoking and drinking habits are important predictors of Helicobacter pylori eradication. [2008]
Role of sequential therapy in Helicobacter pylori eradication therapy. [2007.10]
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. [2007.04.17]
Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. [2006.11.15]
The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa. [2006.09]
Efficacy of ronidazole for treatment of feline Tritrichomonas foetus infection. [2006.05]
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. [2006.04.15]
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. [2006.03.21]
Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen. [2006.02]
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. [2006.01.17]
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. [2005.11]
Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study. [2005.07]
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. [2005.06.15]
Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. [2005.05.15]
Twice-daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomized controlled trial using standard and double doses of omeprazole in triple therapy. [2005.03]
Comparison of one week and two weeks of triple therapy for the eradication of Helicobacter pylori in a Sri Lankan population: a randomised, controlled study. [2004.12]
Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. [2004.12]
Helicobacter pylori eradication in children and adolescents by a once daily 6-day treatment with or without a proton pump inhibitor in a double-blind randomized trial. [2004.08.01]
Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial. [2004.08]
The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. [2004.06.15]
Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity. [2004.06]
Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia. [2004.05.01]
The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study. [2004.05]
Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study. [2004.04]
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. [2004.02.15]
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments. [2003.10.15]
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'. [2003.10.15]
Use of bovine lactoferrin for Helicobacter pylori eradication. [2003.10]
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy. [2003.09.15]
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. [2003.09.15]
[Usefulness of 2 coproparasitological methods and their utilization in an antigiardiasis therapeutic trial] [2003.09]
One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing. [2003.09]
Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment. [2003.07.01]
Rabeprazole in a one-week eradication therapy of Helicobacter pylori: comparison of different dosages. [2003.07]
Use of lactoferrin for Helicobacter pylori eradication. Preliminary results. [2003.05]
High eradication rates of Helicobacter pylori with a new sequential treatment. [2003.03.01]
Diagnosis and eradication of Helicobacter pylori in patients with duodenal ulceration in the community. [2003.03]
Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection. A double blind placebo controlled trial. [2003.01]
Single-dose therapy for giardiasis in school-age children. [2002.12]
Levofloxacin based regimens for the eradication of Helicobacter pylori. [2002.12]
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. [2002.11]
[Double blind randomized multicentre study of a seven-day eradication regime of Helicobacter pylori by omeprazole, clarithromycin and ornidazole vs. omeprazole, clarithromycin and metronidazole] [2002.10]
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial. [2002.03]
Two new treatment regimens for Helicobacter pylori eradication: a randomised study. [2001.11]
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. [2001.11]
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy? [2001.07]
[Role of Helicobacter pylori infection in insulin-dependent diabetes mellitus] [2001.06]
Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study. [2001.05]
Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication. [2001.03]
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. [2001.02]
Six regimens for the eradication of Helicobacter pylori (Hp) in duodenal ulcer patients: three consecutive trials (1995-1999). [2001.01]
Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer. [2001.01]
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. [2001]
Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. [2000.12]
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. [2000.12]
In dyspeptic patients without gastric phase III of the migrating motor complex, Helicobacter pylori eradication produces no short-term changes in interdigestive motility pattern. [2000.08]
|